Document is current
Any future updates will be listed below
-
Authors
Hieken, Tina J.
Nelson, Garth D.
Flotte, Thomas J. http://orcid.org/0000-0001-5691-8249
Grewal, Eric P. http://orcid.org/0000-0002-2189-7975
Chen, Jun http://orcid.org/0000-0002-1273-5624
McWilliams, Robert R. http://orcid.org/0000-0002-8199-5040
Kottschade, Lisa A.
Yang, Lu http://orcid.org/0000-0002-5234-3190
Domingo-Musibay, Evidio http://orcid.org/0000-0002-2082-554X
Dronca, Roxana S.
Yan, Yiyi
Markovic, Svetomir N.
Dimou, Anastasios http://orcid.org/0000-0002-3950-3305
Montane, Heather N.
Erskine, Courtney L.
Piltin, Mara A.
Price, Daniel L.
Khariwala, Samir S.
Hui, Jane http://orcid.org/0000-0002-2628-0720
Strand, Carrie A.
Harrington, Susan M.
Suman, Vera J. http://orcid.org/0000-0002-9640-5189
Dong, Haidong http://orcid.org/0000-0002-5782-2983
Block, Matthew S. http://orcid.org/0000-0001-5692-4219
-
Funding
Funding for this research was provided by:
EIF | Stand Up To Cancer (SU2C-AACR-CT10-17)
Mayo Clinic | Center for Clinical and Translational Science, Mayo Clinic (92541640-2020)
- License Information
-
More Information
Article History
Received: 3 October 2023
Accepted: 5 February 2024
First Online: 16 February 2024
Competing interests
: T.J.H.: Research support—Genentech, SkylineDX BV; R.R.M.: Research support—Bristol-Myers Squibb, GSK; L.A.K.: Advisory Board—Immunocore; R.S.D.: Research support—Bristol-Myers Squibb; S.N.M.: Research support—Bristol-Myers Squibb, Sorrento Therapeutics; Intellectual Property: Sorrento Therapeutics; A.D.: Honoraria—Intellisphere, Roche/Genentech; Advisory Board—TP Therapeutics, Guardant Health, AnHeart Therapeutics, ChromaCode; Clinical trial support—Syntrix Pharmaceuticals, Novartis, Merck, AnHeart Therapeutics, Sorrento Therapeutics, Guardant, Philogen, AstraZeneca; M.A.P.: Research funding—Intuitive Surgical; Honoraria—Kubtec Medical Imaging; D.L.P.: Advisory Board and Equity Interest—InSitu Biologics; Advisory Board—Medivis; M.S.B.: Research support—Alkermes, Bristol-Myers Squibb, Genentech, Merck, nFerence, Pharmacylclics, Regeneron, Sorrento Therapeutics, TILT Biotherapeutics, Transgene, Viewpoint Molecular Therapeutics; Consultant/Scientific Advisory Board—Sorrento Therapeutics, TILT Biotherapeutics, Viewpoint Molecular Therapeutics All other authors have no competing interests to declare.
